TRIOGLIMITERIS 1/0.2 combines Voglibose 0.2 mg, Glimepiride 1 mg, and Metformin Hydrochloride 500 mg. This combination is designed to manage type 2 diabetes mellitus, offering a multi-faceted approach to controlling blood sugar levels.

How Does It Work?

• Voglibose: Delays glucose absorption in the intestines, reducing postprandial blood sugar spikes.
• Glimepiride: Stimulates insulin release from the pancreas, aiding in glucose utilization.
• Metformin Hydrochloride: Decreases glucose production in the liver and improves insulin sensitivity.

Uses of TRIOGLIMITERIS 1/0.2

• Effective management of type 2 diabetes mellitus.
• Helps in maintaining overall blood glucose levels.

What is TRIOGLIMITERIS 1/0.2?

TRIOGLIMITERIS 1/0.2 is an oral antidiabetic medication used to treat type 2 diabetes. The combination of three different drugs offers comprehensive blood sugar control.

Side Effects

• Gastrointestinal discomfort
• Hypoglycemia (low blood sugar)
• Nausea and vomiting
• Abdominal pain

Safety Information

• Monitor blood sugar levels regularly.
• Use caution if you have kidney or liver problems.
• Avoid alcohol as it may increase the risk of lactic acidosis with metformin.

Key Benefits

• Comprehensive Blood Sugar Control: Targets multiple pathways to effectively manage diabetes.
• Reduced Postprandial Glucose: Voglibose helps control sugar spikes after meals.
• Enhanced Insulin Sensitivity: Metformin improves the body's response to insulin.

If You Need More Information About  TRIOGLIMITERIS 1/0.2  Click here